MAC
67
2
MAR
68
-3
LH
40
-3
MO
51
-6
CCL
65
3
TRIP
47
-5
PEG
46
2
MNST
55
3
SCHW
58
2
HRB
42
-2
IR
55
-11
HD
32
-2
VTR
70
3
WHR
55
2
AVY
54
-7
DLTR
62
-4
HUM
42
8
AMZN
52
4
STZ
44
-3
HPQ
35
-4
MAC
67
2
MAR
68
-3
LH
40
-3
MO
51
-6
CCL
65
3
TRIP
47
-5
PEG
46
2
MNST
55
3
SCHW
58
2
HRB
42
-2
IR
55
-11
HD
32
-2
VTR
70
3
WHR
55
2
AVY
54
-7
DLTR
62
-4
HUM
42
8
AMZN
52
4
STZ
44
-3
HPQ
35
-4
Financhill
Back

Invesco DB Commodity Index Tracking Fund Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
31

DBC
Invesco DB Commodity Index Tracking Fund

Last Price:
$22.85
Seasonality Move:
2.3%
Sell
18

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$33.50
Seasonality Move:
-0.96%
Sell
31
Invesco DB Commodity Index Tracking Fund (DBC) is a Sell

Is Invesco DB Commodity Index Tracking Fund a Buy, Sell or Hold?

  • The current Invesco DB Commodity Index Tracking Fund [DBC] share price is $22.69. The Score for DBC is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • DBC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $32.84. The Score for RARE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DBC Stock Price Chart

What is Invesco DB Commodity Index Tracking Fund's stock price today?

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $32.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

DBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 45.07 Sell
Chaikin Money Flow: -161740 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.7 - 23.14) Sell
Bollinger Bands (100): (22.09 - 22.93) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.67 Buy
Relative Strength Index (14 RSI): 41.45 Sell
Chaikin Money Flow: -1089594 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.6 - 35.94) Sell
Bollinger Bands (100): (29.09 - 34.15) Buy

DBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.89 Sell
20-day SMA: 22.91 Sell
50-day SMA: 22.78 Sell
200-day SMA: 22.12 Buy
8-day EMA: 22.84 Sell
20-day EMA: 22.9 Sell
50-day EMA: 22.39 Buy
200-day EMA: 14.29 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.17 Sell
20-day SMA: 34.68 Sell
50-day SMA: 33.7 Sell
200-day SMA: 33.61 Sell
8-day EMA: 13.04 Buy
20-day EMA: 5.99 Buy
50-day EMA: 2.54 Buy
200-day EMA: 0.65 Buy

Invesco DB Commodity Index Tracking Fund Earnings Growth & DBC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Invesco DB Commodity Index Tracking Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):